Management of Cancer-related Cognitive Dysfunction-Conceptualization Challenges and Implications for Clinical...

Area of Science:

• Oncology
• Neuroscience
• Psychology

Background:

• Cancer-related cognitive dysfunction (CRCD) affects a substantial portion of cancer patients and survivors, with reported incidence rates varying widely from 17% to 75%.
• Cognitive impairments, particularly in attention and memory, can be severe and persist long after cancer treatment concludes.
• The exact causes of CRCD remain unclear, complicating the development of effective management strategies.

Purpose of the Study:

• To provide a comprehensive overview of the current understanding of cancer-related cognitive dysfunction.
• To discuss the pathophysiology, prevailing theories, and clinical manifestations of CRCD.
• To highlight challenges in assessment and explore potential management approaches for CRCD.

Main Methods:

• This article synthesizes existing literature on CRCD.
• It reviews current research on the etiology and assessment of cognitive impairment in cancer patients.
• The discussion includes pathophysiology, clinical presentation, and management strategies.

Main Results:

• CRCD is a prevalent and potentially long-lasting condition affecting cancer patients and survivors.
• Significant challenges exist in determining the precise causes and establishing standardized assessment methods for CRCD.
• Current understanding of CRCD's pathophysiology and effective management remains limited.

Conclusions:

• CRCD presents a significant clinical challenge due to its high incidence and persistent nature.
• Further research is crucial to elucidate the underlying mechanisms of CRCD and develop reliable assessment tools.
• Developing evidence-based management strategies is essential to improve the quality of life for affected individuals.